Preventive effects of pectin with various degrees of esterification on ulcerative colitis in mice

2020 ◽  
Vol 11 (4) ◽  
pp. 2886-2897 ◽  
Author(s):  
Linlin Fan ◽  
Sheng Zuo ◽  
Huizi Tan ◽  
Jielun Hu ◽  
Jiaobo Cheng ◽  
...  

Low esterified or amidated low esterified pectin displayed better preventive effects on acute colitis over high esterified pectin.

2018 ◽  
Vol 315 (6) ◽  
pp. G909-G920 ◽  
Author(s):  
Lanju Wang ◽  
Yaohui Wang ◽  
Zhenfeng Wang ◽  
Yu Qi ◽  
Beibei Zong ◽  
...  

Growth differentiation factor 11 (GDF11) has an anti-inflammatory effect in the mouse model of atherosclerosis and Alzheimer's disease, but how GDF11 regulates intestinal inflammation during ulcerative colitis (UC) is poorly defined. The Nod-like receptor family pyrin domain-1 containing 3 (NLRP3) inflammasome is closely associated with intestinal inflammation because of its ability to increase IL-1β secretion. Our aim is to determine whether GDF11 has an effect on attenuating experimental colitis in mice. In this study, using a dextran sodium sulfate (DSS)-induced acute colitis mouse model, we reported that GDF11 treatment attenuated loss of body weight, the severity of the disease activity index, shortening of the colon, and histological changes in the colon. GDF11 remarkably suppressed IL-1β secretion and NLRP3 inflammasome activation in colon samples and RAW 264.7 cells, such as the levels of NLRP3 and activated caspase-1. Furthermore, we found that GDF11 inhibited NLRP3 inflammasome activation by downregulating the Toll-like receptor 4/NF-κB p65 pathway and reactive oxygen species production via the typical Smad2/3 pathway. Thus, our research shows that GDF11 alleviates DSS-induced colitis by inhibiting NLRP3 inflammasome activation, providing some basis for its potential use in the treatment of UC. NEW & NOTEWORTHY Here, we identify a new role for growth differentiation factor 11 (GDF11), which ameliorates dextran sodium sulfate-induced acute colitis. Meanwhile, we discover a new phenomenon of GDF11 inhibiting IL-1β secretion and Nod-like receptor family pyrin domain-1 containing 3 (NLRP3) inflammasome activation. These findings reveal that GDF11 is a new potential candidate for the treatment of ulcerative colitis patients with a hyperactive NLRP3 inflammasome.


2014 ◽  
Vol 89 (5) ◽  
pp. 593-600 ◽  
Author(s):  
M.C. Vegas-Sánchez ◽  
E. Rollán-Landeras ◽  
J.J. García-Rodríguez ◽  
F. Bolás-Fernández

AbstractThe aim of this study was to assess the effect of infection with the nematode whipworm Trichuris muris on the course of chemically induced acute ulcerative colitis in CBA/J mice, a strain proven to be highly resistant to infection with T. muris. Each mouse was infected with 50 embryonated eggs of T. muris by oral gavage. Acute colitis was triggered by administering 4% dextran sulphate sodium (DSS) in the drinking water for nine consecutive days at different times after infection. Concurrent infection and DSS administration exacerbate the severity of the colitis while favouring the permanence of parasites in the intestine. The induction of ulcerative colitis from days 54 to 62 post-infection (p.i.), when all worms had been expelled, ameliorated the course of the inflammatory disease. When ulcerative colitis was triggered earlier on, from days 27 to 35 p.i., the beneficial effects on inflammatory events were clearly shown with signs of mucosal epithelization and regeneration as early as day 1 after DSS administration. Previous infections by T. muris therefore accelerate recovery from subsequently induced inflammatory bowel disease and such an effect assists the nematode to persist in the intestinal niche.


PEDIATRICS ◽  
1966 ◽  
Vol 38 (2) ◽  
pp. 299-302
Author(s):  
JOYCE D. GRYBOSKI ◽  
FREDERICK BURKLE ◽  
RICHARD HILLMAN

An infant is reported who developed acute colitis on three occasions after the ingestion of milk. It is suggested that milk-induced colitis in this infant is a disease which is distinct from ulcerative colitis but one which must be added to the spectrum of causes operative in the development of colitis in infants and young children.


Author(s):  
I.P. Kotlyar ◽  
◽  
H.M. Kuznіetsova ◽  
V.K. Rybalchenko ◽  
◽  
...  

Inflammatory bowel disease (IBD) which includes ulcerative colitis (UC), is one of the most serious and currently unsolved problems in modern gastroenterology. In terms of severity and frequency of complications, IBD occupies one of the leading places in the structure of gastrointestinal tract diseases. The etiology of IBD is still not fully understood. It is probably of an autoimmune nature, and the main causes are considered to be hereditary predisposition, allergic reactions, nutrition, etc. Dystrophic and atrophic changes of the colonic mucosa, accompanied by its secretory and motor function alterations, digestive disorders, as well as extraintestinal manifestations (general intoxication, liver and skin injuries, joints) are main IBD features. Because tumor growth is usually accompanied by inflammation of tumor nodules in adjacent apparently normal tissue, and prolonged pharnaceutical suppression of inflammation significantly reduces the risk of tumor development, chronic UC is considered as a precursor condition. Moreover, the number of colorectal cancer cases among people with UC history exceeding 10 years, increases eightfold compared to the average population. In this regard, it is important to prevent this pathology, in particular with the help of food supplements of natural origin, such as vegetable oils of flax and milk thistle, which are used in traditional medicine, including inflammatory diseases of the digestive system. Studies on their possible anti-inflammatory effects on the colonic mucosa and biochemical parameters of blood in ulcerative colitis have not been performed. Therefore, the aim is to evaluate the anti-inflammatory effectiveness of vegetable oils (flaxseed and milk thistle, obtained by different methods of pressing) in a model of acute colitis in rats. Object of research: biochemical mechanisms of realization of influence of thistle and flaxseed oils of different methods of extraction at ulcerative colitis. The effects of linseed and milk thistle oils obtained by cold pressing (to 45°C) and hot pressing (to 95°C) on the development of acute colitis in rats, when administered with food, have been investigated. It was shown that the use of linseed oil both cold and hot-pressed under conditions of adding it to the feed in an amount of 10% for 2 weeks prevents the development of inflammatory and destructive changes in the colon of rats with acute colitis and its negative consequences in the liver (for approaching to the normal values of serum markers of its functional activity). These oil properties could be realized partially by unsaturated fatty acids, in particular ω3, including minor ones. The data obtained may indicate that one of the mechanisms of implementation of the anti-inflammatory action of these substances is their ability to reduce oxidative stress - one of the main factors and promoters of inflammation.


2021 ◽  
Vol 12 ◽  
Author(s):  
Yingyu Lu ◽  
Jianqiang Chen ◽  
Xueling He ◽  
Shuoxi Xu ◽  
Yong-er Chen ◽  
...  

With the increasing incidence of ulcerative colitis (UC) in China, Chinese medicinal herbs or relatively active compounds are widely applied in treating UC. These medicines may be combined with other therapeutic agents such as vitamin D3. Nevertheless, the efficacy of these combinations for UC is unclear. Geniposide is an active component in many Chinese herbal medicines. It could ameliorate dextran sulfate sodium (DSS)–induced colitis in mice. This study was designed to determine the efficacy and mechanism of the single use and combination of geniposide and vitamin D3 on a mouse model of acute colitis. Data showed that a single administration of geniposide (2 mg/kg) or vitamin D3 (4 IU/day) could significantly improve the symptoms of UC and relieve colon damage. Geniposide and vitamin D could significantly decrease the levels of TNF-α and IL-6 in serum and colon, and increase the level of IL-10 in the colon. However, the combined treatment of geniposide (2 mg/kg) and vitamin D3 (4 IU/day) exerted less beneficial effects on UC in mice, indicating by less improvement of UC symptoms, colon damage, and inflammatory infiltration. The combination only downregulated the level of TNF-α in serum and IL-6 in the colon. Our data further demonstrated that geniposide could inhibit the activation of p38 MAPK and then restrict the vitamin D receptor signaling stimulated by vitamin D3. These results implied that the combination of geniposide and vitamin D3 might not be an ideal combined treatment for acute colitis, and the combination of vitamin D supplementary and geniposide (or herbal medicines rich in geniposide) need more evaluation before being applied to treat UC in clinic.


2021 ◽  
Vol 14 (10) ◽  
pp. e243284
Author(s):  
Miori Kido ◽  
Ryo Tamura ◽  
Yoshitomo Yasui ◽  
Hideaki Okajima

Diversion colitis (DC) that was refractory to standard treatments was successfully treated with infliximab. A 24-year-old man with a transverse colostomy suffered from severe DC. Topical steroids, 5-aminosalicylic acid (5-ASA) enemas and synbiotics were initially effective, and the colostomy was successfully closed with a covering ileostomy to minimise the risk of anastomotic leakage owing to the damaged colon. DC subsequently relapsed in the entire colon and was refractory to the previous protocol and autologous faecal transplantation. Intravenous methylprednisolone and oral 5-ASA were discontinued owing to possible adverse effects. Infliximab with intravenous prednisolone was introduced, and the protocol was so effective in suppressing the acute colitis that total colectomy was avoided. The stoma was subsequently closed, and the patient is currently symptom-free. Infliximab is used for ulcerative colitis but could also be effective against severe DC.


2021 ◽  
Vol 11 ◽  
Author(s):  
Bingyu Wang ◽  
Zhiqiang Gong ◽  
Jingyu Zhan ◽  
Lei Yang ◽  
Quanyu Zhou ◽  
...  

Xianglian pill (XLP) is a typical traditional Chinese herbal medicine prescription composed of Coptidis Rhizoma and Aucklandiae Radix. It has been used to treat gastrointestinal disease for centuries. In the present study, the potential mechanisms of XLP in the treatment of ulcerative colitis (UC) were predicted by integrative pharmacology-based approach. Then, the main compounds of XLP were detected by liquid chromatography-mass spectrometry (LC-MS/MS). Finally, we verified the mechanism of XLP in the treatment of UC in a dextran sulfate sodium (DSS) model. C57BL/6 mice were randomly divided into the control group, DSS group, 5-aminosalicylic acid (5-ASA) group which was used as the positive drug control, XLP low, medium, and high dose group, with 10 mice per group. Except for the control group, acute colitis model was induced in the other mice by administering 3% DSS for consecutive 7 days. Mice in 5-ASA and XLP groups were administered with 5-ASA (50 mg/kg) or XLP (0.8, 1.6, 3.2 g/kg) via oral gavage once per day respectively. Body wight and disease activity index were assay during drug intervention. On day 8, all animals in this experiment were sacrificed and colon tissues were collected for analysis after measurement of the length. The results showed that XLP alleviate DSS -induced acute colitis in mice, including inhibition the secretion of pro-inflammatory cytokines, repairing the dysfunction of intestinal epithelial barrier, enhanced autophagy, and blocked the activation of PI3K/Akt/mTOR pathway. Furthermore, inhibiting autophagy by 3-methyladenine attenuated the protective effects of XLP on colitis. The underlying mechanism may be that Xianglian pill promote autophagy by blocking the activation of PI3K/Akt/mTOR signaling pathway.


BMJ ◽  
1907 ◽  
Vol 1 (2423) ◽  
pp. 1355-1360
Author(s):  
S. Phillips

Sign in / Sign up

Export Citation Format

Share Document